0% 26feb2048 (19KY)

https://investorshub.advfn.com/uimage/uploads/2026/7/10/ryywbnrc_july_10_1y_reserve.jpg

Ouch ☹️ Doesn't bode well for us in Germany.

This is when they meet then FDA approval decisions after PCAC review…we are early

https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3

IT IS DAMNED IF IT GOES UP, DAMNED IF IT GOES DOWN! Which is it??? I repeat: IT IS DAMNED IF IT GOES UP. []DAMNED IF IT GOES DOWN! Let it flow fre

https://youtu.be/KFgPl1lmYx4?si=WFyjrgaKO4e3Hz03

I did not use that term in any response to you. The point is the same. Everyone wants to know when the BFS will be released, and they are not going to respond with anything specific.

German lawmakers pass cost-saving healthcare legislation that pharmaceutical/drugmaker companies say will drive them out of that market, per Endpoints News today.

I guess my order was the only thing keeping it above .1780 🤷

This is odd, I thought you had said you had sold your shares and were no longer going to be posting since you were "back to monitoring".

I believe that this dilution from the preferred K should’ve already been in the stock price, but it looks like it has not, and the prices come down considerably which I think is way overkillThe Preferred K was already there from the old ownership!!!! 

SNAL About

Snail, Inc. is an independent developer and publisher of interactive digital entertainment. The firm builds a portfolio of games designed for use on a variety of platforms, including consoles, PCs, and mobile devices. Its portfolio of games includes ARK:Survival Evolved, La

Is there a timeline for empty shells to stay on OTC Market without merging, or could this stay like this for years, as long as Currier keeps her simple financial updates each year? She is in no rush what so ever.

Need to see a filing on the will(I assume he had one) . Once probated we will know more. But it will not change all the baggage!

standard games on all thinly traded stocks regardless of what exchange they are on. lack of demand for the stock is the primary culprit

It’s an editorial communication paid for by……

BLIS.

It’s in the disclaimer.

Has anyone been able to make contact with Obera?

If so, please share.

Thx

Does anyone here really believe that SK wants to go thru litigation again with NLST ? This making NLST sound like they have no leg to stand on is BS I'm getting real tired of hearing it ..
How did SK make all there money? using NLST technology thats how...

Zack is ranking AMRN rank # 1 Strong Buy out of 4000 stocks!

"In simple terms, during a downtrend, with bears having absolute control, a stock usually opens lower compared to the previous day's close, and again closes lower. On the day the hammer pattern is formed, maintaining the dow

$EBYH volume now is active....https://www.otcmarkets.com/stock/EBYH/overview....word is starting to get out on data center

Marco:
I am very concerned this will go ubiquitous. 😉

L_R

maybe they'll do a reunion song !

lol....

Just filled the rest of it. Just pointing out how weird this stock trades...

Edit: Now I have 20k more shares for Marzan Monday...😅

$EBYH volume now is active....https://www.otcmarkets.com/stock/EBYH/overview....word is starting to get out on data center

My man, keep on doing what you do. Not everyone here is your audience. I appreciate the digging even if it leads to dead ends. 

At least it’s something out of nothing. 

I think it's because no one
knows what ERCF stands for

U.S. Patent No. 5,972,911 and U.S. Patent No. 4,874,795 are both currently assigned to Biomolecular Products, Inc. (a Massachusetts corporation founded by inventor David W. Yesair). patents.google.com patents.google.com
• These patents cover compositions for the delivery of orally administ